HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gezhi Xu Selected Research

Degenerative Myopia

12/2020Gradual healing of macular retinoschisis after photodynamic therapy for choroidal neovascularization in pathological myopia eyes.
3/2020Pathological myopia-induced antioxidative proteins in the vitreous humor.
12/2016Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.
3/2013Mechanical stretching induces matrix metalloproteinase-2 expression in rat retinal glial (Müller) cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gezhi Xu Research Topics

Disease

18Retinal Detachment (Retinal Detachments)
03/2022 - 11/2010
15Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 09/2009
9Inflammation (Inflammations)
01/2021 - 02/2013
8Central Serous Chorioretinopathy
10/2022 - 05/2014
8Endophthalmitis (Ophthalmia)
05/2021 - 05/2009
7Macular Edema
07/2022 - 01/2018
7Choroidal Neovascularization
10/2021 - 12/2014
7Retinal Degeneration
08/2021 - 11/2013
7Retinal Perforations
03/2021 - 11/2012
6Macular Degeneration (Age-Related Maculopathy)
01/2022 - 09/2014
6Retinoschisis (Retinoschisis, Juvenile)
01/2021 - 06/2010
6Myopia
12/2019 - 09/2014
5Epiretinal Membrane (Epiretinal Membranes)
03/2022 - 03/2018
5Fibrosis (Cirrhosis)
01/2022 - 11/2017
5Uveitis
01/2021 - 01/2017
4Degenerative Myopia
12/2020 - 03/2013
4Wounds and Injuries (Trauma)
11/2020 - 03/2014
3Retinal Vein Occlusion
07/2022 - 01/2018
3Gliosis
01/2020 - 01/2018
3Hemorrhage
01/2020 - 01/2019
3Edema (Dropsy)
02/2011 - 06/2009
2Bites and Stings (Sting)
06/2022 - 10/2020
2Polypoidal Choroidal Vasculopathy
06/2022 - 02/2022
2Vitreous Hemorrhage
06/2022 - 05/2021
2Neoplasms (Cancer)
03/2022 - 11/2010
2Atrophy
01/2022 - 12/2021
2Papilledema
01/2022 - 11/2009
2Lymphoma (Lymphomas)
01/2022 - 12/2021
2Aneurysm (Aneurysms)
10/2021 - 01/2020
2Ischemia
03/2021 - 01/2021
2Toxocariasis
04/2020 - 09/2012
2Telangiectasis (Telangiectasia)
04/2019 - 03/2018
2Glaucoma
01/2018 - 09/2012
2Type 2 Diabetes Mellitus (MODY)
04/2015 - 09/2011
2Hemangioma (Angioma)
02/2011 - 11/2010
1Retinal Vasculitis
01/2022
1Polyneuropathies (Polyneuropathy)
01/2022
1Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
01/2022
1Inborn Genetic Diseases (Disease, Hereditary)
01/2022
1Acute Retinal Necrosis Syndrome
11/2021
1Cataract (Cataracts)
05/2021
1Foreign Bodies (Foreign Body)
05/2021
1Rupture
05/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Ocular Hypertension (Glaucoma, Suspect)
01/2021
1Neuroinflammatory Diseases
01/2021

Drug/Important Bio-Agent (IBA)

34Retinaldehyde (Retinal)IBA
06/2022 - 11/2009
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2022 - 10/2010
8Proteins (Proteins, Gene)FDA Link
06/2022 - 11/2017
5Fluorescein (Funduscein)FDA LinkGeneric
01/2021 - 11/2010
5GlucocorticoidsIBA
01/2020 - 01/2017
41-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2022 - 11/2010
4KH902 fusion proteinIBA
02/2022 - 09/2014
4Silicone OilsIBA
11/2021 - 01/2020
4EndotoxinsIBA
01/2021 - 12/2017
4LipopolysaccharidesIBA
01/2021 - 12/2017
3CytokinesIBA
11/2021 - 04/2017
3Peptides (Polypeptides)IBA
01/2020 - 01/2018
3Aquaporins (Water Channels)IBA
01/2018 - 11/2009
2Ranibizumab (Lucentis)FDA Link
07/2022 - 12/2014
2Mitochondrial DNA (mtDNA)IBA
06/2022 - 10/2020
2Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2018
2Anti-Bacterial Agents (Antibiotics)IBA
02/2020 - 01/2017
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 11/2014
2Glial Fibrillary Acidic ProteinIBA
01/2019 - 01/2018
2salicylhydroxamic acid (SHAM)IBA
01/2019 - 01/2018
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2018 - 10/2012
2Lipocalin-2IBA
12/2018 - 01/2018
2MelatoninIBA
01/2016 - 01/2012
2AntioxidantsIBA
01/2016 - 10/2012
2Insulin (Novolin)FDA Link
10/2012 - 09/2011
2SaltsIBA
11/2009 - 06/2009
1Protons (Proton)IBA
02/2022
1Complement System Proteins (Complement)IBA
01/2022
1Prealbumin (Transthyretin)IBA
01/2022
1Complement C1q (C1q Complement)IBA
01/2022
1ProteomeIBA
01/2022
1LipidsIBA
09/2021
1Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2021
12-toluenesulfonamide (OTS)IBA
05/2021
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
01/2021
1Antiglaucoma AgentsIBA
01/2021
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2021
1InterferonsIBA
01/2021
1Therapeutic UsesIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1ferrostatin-1IBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1MetalsIBA
11/2020
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2020

Therapy/Procedure

25Vitrectomy
06/2022 - 05/2009
9Photochemotherapy (Photodynamic Therapy)
10/2022 - 11/2010
9Therapeutics
07/2022 - 09/2011
8Intravitreal Injections
01/2021 - 10/2016
5Light Coagulation
03/2022 - 12/2010
5Lasers (Laser)
03/2022 - 11/2010
4Traction
12/2021 - 09/2014
3Injections
07/2022 - 09/2014
3Aftercare (After-Treatment)
01/2022 - 02/2020
1Intraocular Lens Implantation
09/2020